Have you been diagnosed with LGMD2D/R3? Join our patient registry.

  • Home
  • About Us
    • About Our Foundation
    • Meet Our Team
    • What is LGMD2D/R3?
    • LGMD2D Awareness Video
  • Patient Registry
  • Patient Resources
  • LGMD2D Research
  • Support by Donating
  • LGMD2D Events
    • Hope in Motion Virtual 5k
    • 2025 Golf Tournament
    • 2026 Golf Tournament
  • Contact Us
  • LGMD Press Release
  • More
    • Home
    • About Us
      • About Our Foundation
      • Meet Our Team
      • What is LGMD2D/R3?
      • LGMD2D Awareness Video
    • Patient Registry
    • Patient Resources
    • LGMD2D Research
    • Support by Donating
    • LGMD2D Events
      • Hope in Motion Virtual 5k
      • 2025 Golf Tournament
      • 2026 Golf Tournament
    • Contact Us
    • LGMD Press Release
  • Home
  • About Us
    • About Our Foundation
    • Meet Our Team
    • What is LGMD2D/R3?
    • LGMD2D Awareness Video
  • Patient Registry
  • Patient Resources
  • LGMD2D Research
  • Support by Donating
  • LGMD2D Events
    • Hope in Motion Virtual 5k
    • 2025 Golf Tournament
    • 2026 Golf Tournament
  • Contact Us
  • LGMD Press Release
LGMD2D Foundation

Ongoing Research & Trials

Clinical Trials:

Gene Therapy - 

Study Details | Study to Evaluate the Safety, Tolerability, and Efficacy of SRP-9004 Administered by Systemic Infusion in Limb Girdle Muscular Dystrophy Type 2D/R3 Participants in the United States | ClinicalTrials.gov

  • Sponsor:  Sarepta Therapeutics, Inc.
  • Recruitment Status: Closed


Natural History Studies:

Defining Clinical Endpoints in Limb Girdle Muscular Dystrophy (LGMD) (GRASP-01-001) 

  • Sponsor:  Virginia Commonwealth University
  • Recruitment Status: Active


A Study of the Natural History of Patients With LGMD2E/R4, LGMD2D/R3, and LGMD2C/R5, ≥ 4 Years of Age, Who Are Managed in Routine Clinical Practice

  • Sponsor: Sarepta Therapeutics, Inc.
  • Recruitment Status: Closed


Skeletal Muscle Biomarkers in People With Fragile Sarcolemmal Muscular Dystrophy

  • Sponsor: Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
  • Recruitment Status: Active, Not Recruiting

Past Gene Therapy Trials

Gene Therapy Trial for LGMD2D

Gene Therapy Trial for LGMD2D

Gene Therapy Trial for LGMD2D

Sponsored by Nationwide Children's Hospital 

Status: Completed

Discover More

LGMD2D Gene Therapy

Gene Therapy Trial for LGMD2D

Gene Therapy Trial for LGMD2D

Sponsored by Nationwide Children's Hospital

Status: Completed

Discover More

Research Highlights

Publications

Gene Therapy


Gene Delivery for Limb-Girdle Muscular Dystrophy Type 2D by Isolated Limb Infusion - July 2019


Sustained alpha-sarcoglycan gene expression after gene transfer in limb-girdle muscular dystrophy, type 2D - November 2010


Limb-girdle muscular dystrophy type 2D gene therapy restores alpha-sarcoglycan and associated proteins - September 2009


Early adenovirus-mediated gene transfer effectively prevents muscular dystrophy in alpha-sarcoglycan-deficient mice - August 2000


Small Molecule


Repairing the defective folding of alpha-sarcoglycan is needed to promote myogenic cell engraftment in 3D artificial muscle models of LGMDR3 - PubMed - December 2025


The novel use of the CFTR corrector C17 in muscular dystrophy: pharmacological profile and in vivo efficacy - ScienceDirect - March 2025


Dual Blockade of Misfolded Alpha-Sarcoglycan Degradation by Bortezomib and Givinostat Combination - PubMed - April 2022


Muscular Dystrophy Association: Research on LGMD

Alpha-Sarcoglycan Mouse Models

We have multiple alpha-sarcoglycan mouse models available for research:


Mutant Mouse Resource and Research Center (MMRRC) - 

MMRRC:000425-MU 


Jackson Laboratory - 


B6.129S6-Sgcatm2Kcam/J (stock #008275) 


B6.Cg-Sgcatm1KamTg(Ckm-SGCE)1Kcam/J (stock #009651) 


Genetic Tools

DNA and RNA primers for PCR amplification

Antibody Resources

Abcam antibodies against alpha-sarcoglycan

  • Anti-alpha Sarcoglycan antibody [Ad1/20A6] (ab49451)
  • Anti-alpha Sarcoglycan antibody (ab92522) 
  • Anti-alpha Sarcoglycan antibody (ab130657) 

Links on Biocompare to antibodies from 16 different vendors 

Links on Antibody Resource to antibodies from 12 different vendors 

R&D Systems alpha-sarcoglycan antibody

Additional Resources

Bioz analyzes, aggregates, and structures data from more than 3.6 million articles and many different resources related to alpha-sarcoglycan can be found on this website.

Together for a Cure

Your generous donation will help support research to find effective treatments or a cure for 

LGMD2D / R3.

Pay with PayPal or a debit/credit card

LGMD2D Foundation

Copyright © 2026 LGMD2D Foundation - All Rights Reserved. LGMD2D Foundation is a 501(c)(3), EIN # 46-4128016. Est. 2013.

Powered by

Support LGMD2D Warriors

There are currently no approved treatments or a cure for LGMD2D. The incredible warriors fighting this disease around the world need your support. Please consider making a donation—no dollar is too small, and every dollar goes directly toward raising LGMD2D/R3 awareness, advocating for families, and driving the development of life-changing treatments. Join us in this critical mission. Your support truly makes a difference. 

Help Now

This website uses cookies.

We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.

Accept